Preparation of Chiral Hydroxy Esters Using Actinobacteria: Biocatalyst Activity of Marine-Derived <i>Micromonospora</i> and <i>Streptomyces</i> Strains

ISSN Print: 2165-3917
ISSN Online: 2165-3925
www.scirp.net/journal/ojapps
E-mail: [email protected]

Citations

"Preparation of Chiral Hydroxy Esters Using Actinobacteria: Biocatalyst Activity of Marine-Derived Micromonospora and Streptomyces Strains"
written by Kohji Ishihara, Aiko Fujita, Akane Sakiyama, Yuko Kobayashi, Kaoru Hori, Kanako Maruike, Noriyoshi Masuoka, Nobuyoshi Nakajima, Hiroki Hamada,
published by Open Journal of Applied Sciences, Vol.3 No.1, 2013

has been cited by the following article(s):

[1]	Biotechnological Properties of Sponges from Northeast Brazil: Cliona varians as a Biocatalyst for Enantioselective Reduction of Carbonyl Compounds
	2019

[2]	Microbial Production of Chiral Hydroxy Esters and Their Analogs: Biocatalytic Reduction of Carbonyl Compounds by Actinobacteria, Agromyces and Gordonia …
	2019

[3]	Biocatalytic Reduction of Carbonyl Compounds by Actinobacteria from Two Genera of the Micromonosporaceae Family: Actinoplanes and Dactylosporangium
	2019

[4]	Biocatalytic reduction of carbonyl compounds by actinobacteria from two genera of the micromonosporaceas family: Actinoplanes and Dactylosporangium
	2019

[5]	Microbial Preparation of Chiral Alcohols: Stereoselective Reduction of Carbonyl Compounds using Two Genera of the Streptosporangiaceae Family …
	2017

[6]	Integrated (Meta) Genomic and Synthetic Biology Approaches to Develop New Biocatalysts
	Marine drugs, 2016

[7]	Biocatalytic Preparation of Chiral Alcohols: Stereoselective Reduction of Carbonyl Compounds using Two Strains of the Streptomycetaceae family-Streptacidiphilus and Kitasatospora
	Int. J. Curr. Microbiol. App. Sci, 2015

[1]	6-Isoprenylindole-3-carboxylic Acid with an Anti-Melanogenic Activity from a Marine-Derived Streptomyces sp. APA-053 Marine Drugs, 2025 DOI:10.3390/md23120448

[2]	Integrated (Meta) Genomic and Synthetic Biology Approaches to Develop New Biocatalysts Marine Drugs, 2016 DOI:10.3390/md14030062